Insulet | PODD - Lucro Bruto Sobre Vendas

Preço das Ações
172.06
Mudança Diária
12.04 7.52%
Mensal
-18.00%
Anual
-31.24%
Q2 Previsão
185.50




Lucro Bruto Sobre Vendas Alterar Data
Abbott USD 5.86B 675M 2026-03
Align Technology USD 736.59M 53M 2026-03
AtriCure USD 105.34M 4M 2025-12
Avanos Medical USD 86M 0 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.61B 64M 2026-03
Cardinal Health USD 2.5B 101M 2026-03
Cooper Companies USD 695.2M 44.4M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Eli Lilly USD 15.92B 1.33B 2025-12
Globus Medical USD 535.95M 49.28M 2025-12
ICU Medical USD 202.98M 2.1M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
J&J USD 17.24B 642M 2026-03
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Solventum Corp USD 1.03B 108M 2025-12
Stryker USD 4.49B 633M 2025-12
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
West Pharmaceutical Services USD 296.4M 7.5M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12